Impact of exacerbations of cystic fibrosis on muscle strength

[1]  D. Hansell,et al.  Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation , 2013, Thorax.

[2]  J. Cracowski,et al.  Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. , 2013, Chest.

[3]  J. Britton,et al.  Are measures of body habitus associated with mortality in cystic fibrosis? , 2012, Chest.

[4]  L. Atallah,et al.  Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[5]  F. Maltais,et al.  Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. , 2012, Chest.

[6]  S. Doucette,et al.  Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis , 2011, Thorax.

[7]  M. Proesmans,et al.  Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  Margaret Rosenfeld,et al.  Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis , 2011, Pediatric pulmonology.

[9]  Tiffany J Dwyer,et al.  Evaluation of the SenseWear activity monitor during exercise in cystic fibrosis and in health. , 2009, Respiratory medicine.

[10]  R. Gosselink,et al.  Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis , 2009, European Respiratory Journal.

[11]  C. Gallagher,et al.  Androgens, exercise capacity, and muscle function in cystic fibrosis. , 2008, Chest.

[12]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[13]  A. Almudevar,et al.  Peak oxygen uptake and mortality in children with cystic fibrosis , 2004, Thorax.

[14]  A. Ionescu,et al.  Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[15]  A. Manley Physical Activity And Health: A Report Of The Surgeon General , 2004 .

[16]  C. Mélot,et al.  Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[17]  M. Decramer,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .

[18]  F. Maltais,et al.  Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[19]  M. Mador,et al.  Quadriceps Fatigue After Cycle Exercise in Patients with COPD Compared with Healthy Control Subjects. , 2003, Chest.

[20]  M. Mador,et al.  Comparison of potentiated and unpotentiated twitches as an index of muscle fatigue , 2002, Muscle & nerve.

[21]  H. Selvadurai,et al.  Randomized controlled study of in‐hospital exercise training programs in children with cystic fibrosis , 2002, Pediatric pulmonology.

[22]  M. Hodson,et al.  Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis. , 2000, Clinical science.

[23]  Bowerman,et al.  Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis , 2000, European journal of clinical investigation.

[24]  M. Decramer,et al.  Six minute walking distance in healthy elderly subjects. , 1999, The European respiratory journal.

[25]  M. Polkey,et al.  Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man , 1995, Muscle & nerve.

[26]  H. Fuchs,et al.  Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. , 1994, The New England journal of medicine.

[27]  S. Kelsey,et al.  The prognostic value of exercise testing in patients with cystic fibrosis. , 1992, The New England journal of medicine.

[28]  R. Hornung,et al.  Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. , 2002, Chest.

[29]  Usdhhs Physical Activity and Health: A Report of the Surgeon General , 1996 .